IL-10 promoter polymorphisms influence disease severity and course in psoriasis
Open Access
- 27 August 2003
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 4 (6) , 455-457
- https://doi.org/10.1038/sj.gene.6364004
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New polymorphisms in the IL-10 promoter regionGenes & Immunity, 2000
- Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locusGenes & Immunity, 1999
- Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfaHepatology, 1999
- Polymorphic haplotypes of the interleukin-10 5? flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritisArthritis & Rheumatism, 1999
- Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypesAnnals of the Rheumatic Diseases, 1999
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Mapping of the human IL10 gene and further characterization of the 5' flanking sequenceImmunogenetics, 1997
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Genetic influence on cytokine production and fatal meningococcal diseaseThe Lancet, 1997
- Isolation of the Human Interleukin 10 Promoter. Characterization of the Promoter Activity in Burkitt's Lymphoma Cell LinesCytokine, 1995